Peter Lamb - Feb 15, 2022 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP, Scientific Strategy & CSO
Signature
/s/ Christopher J. Senner, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 15, 2022
Transactions value $
-$375,090
Form type
4
Date filed
2/17/2022, 07:09 PM
Previous filing
Dec 17, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability -$47K -2.53K -0.7% $18.59 361K Feb 15, 2022 Direct F1, F2
transaction EXEL Common Stock Tax liability -$328K -17.7K -4.89% $18.59 343K Feb 15, 2022 Direct F3
holding EXEL Common Stock 17.1K Feb 15, 2022 By 401(k) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021.
F2 Includes 73,241 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F3 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 20, 2019, for which the Compensation Committee certified that Exelixis, Inc. had achieved certain performance criteria on February 3, 2021.
F4 Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 14, 2022.